Information  X 
Enter a valid email address

ReGen Therapeutics Plc (ADI)

  Print      Mail a friend

Friday 31 December, 2010

ReGen Therapeutics Plc

Total voting rights








Immediate Release
31 December 2010


                             ReGen Therapeutics Plc
                           ("ReGen" or the "Company")
                              Total Voting Rights

For  the  purposes  of  the  Disclosure  and Transparency Rules of the Financial
Services  Authority, the Board of ReGen is  required to notify the market of the
following:

As at the date of this announcement, the Company's issued share capital consists
of  78,446,548 ordinary shares with a nominal  value of 0.01 p each, with voting
rights  ("Ordinary Shares").  The Company  does not  hold any Ordinary Shares in
Treasury.

Therefore  the total number of Ordinary Shares in the Company with voting rights
is 78,446,548.

The  above figure of  78,446,548 Ordinary Shares may  be used by shareholders in
the Company as the denominator for the calculations by which they will determine
if  they are required to notify their interest in, or a change to their interest
in,  the share  capital of  the Company  under the Financial Service Authority's
Disclosure and Transparency Rules.


ENDS

For further information:

Percy Lomax
ReGen Therapeutics Plc
Tel: 020 7153 4920

Roland Cornish/Felicity Geidt
Beaumont Cornish Limited
Tel: 020 7628 3396
















This announcement is distributed by Thomson Reuters on behalf of 
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
    
Source: ReGen Therapeutics Plc via Thomson Reuters ONE

[HUG#1476518]